Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
letter
. 1997;75(9):1398–1399. doi: 10.1038/bjc.1997.238

No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer.

T P Manolitsas, P Englefield, D M Eccles, I G Campbell
PMCID: PMC2228221  PMID: 9155067

Full text

PDF
1398

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis M., Hitchcock A., Foulkes W. D., Campbell I. G. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res. 1996 Feb 15;56(4):741–744. [PubMed] [Google Scholar]
  2. Gabra H., Langdon S. P., Watson J. E., Hawkins R. A., Cohen B. B., Taylor L., Mackay J., Steel C. M., Leonard R. C., Smyth J. F. Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer. Clin Cancer Res. 1995 Sep;1(9):945–953. [PubMed] [Google Scholar]
  3. Hampton G. M., Mannermaa A., Winqvist R., Alavaikko M., Blanco G., Taskinen P. J., Kiviniemi H., Newsham I., Cavenee W. K., Evans G. A. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res. 1994 Sep 1;54(17):4586–4589. [PubMed] [Google Scholar]
  4. Hampton G. M., Penny L. A., Baergen R. N., Larson A., Brewer C., Liao S., Busby-Earle R. M., Williams A. W., Steel C. M., Bird C. C. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6953–6957. doi: 10.1073/pnas.91.15.6953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Keldysh P. L., Dragani T. A., Fleischman E. W., Konstantinova L. N., Perevoschikov A. G., Pierotti M. A., Della Porta G., Kopnin B. P. 11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes Cancer. 1993 Jan;6(1):45–50. doi: 10.1002/gcc.2870060109. [DOI] [PubMed] [Google Scholar]
  6. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Magdelénat H., Gerbault-Seureau M., Dutrillaux B. Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer. Int J Cancer. 1994 Apr 1;57(1):63–66. doi: 10.1002/ijc.2910570112. [DOI] [PubMed] [Google Scholar]
  8. Rousseau-Merck M. F., Misrahi M., Loosfelt H., Milgrom E., Berger R. Localization of the human progesterone receptor gene to chromosome 11q22-q23. Hum Genet. 1987 Nov;77(3):280–282. doi: 10.1007/BF00284486. [DOI] [PubMed] [Google Scholar]
  9. Rowe S. M., Coughlan S. J., McKenna N. J., Garrett E., Kieback D. G., Carney D. N., Headon D. R. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res. 1995 Jul 1;55(13):2743–2745. [PubMed] [Google Scholar]
  10. Slotman B. J., Nauta J. J., Rao B. R. Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator. Cancer. 1990 Aug 15;66(4):740–744. doi: 10.1002/1097-0142(19900815)66:4<740::aid-cncr2820660423>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  11. Vierikko P., Kauppila A., Vihko R. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary. Int J Cancer. 1983 Oct 15;32(4):413–422. doi: 10.1002/ijc.2910320404. [DOI] [PubMed] [Google Scholar]
  12. Vorechovský I., Rasio D., Luo L., Monaco C., Hammarström L., Webster A. D., Zaloudik J., Barbanti-Brodani G., James M., Russo G. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res. 1996 Jun 15;56(12):2726–2732. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES